NUTRIONIX, a Paris, France-based developer and supplier of a salt substitute, called K Salt®, has raised €4m in funding.
Investors include existing backer Seventure Partners and new shareholder medical malpractice liability insurance company SHAM and business angels.
The company intends to use the funds to continue its R&D programs (its research facility is based in Rennes) and expand in France and internationally.
Led by Jean‐Luc Treillou, President and CEO, NUTRIONIX is an expert in mineral blends and in reducing sodium chloride contents in salt in both human and animal nutrition. Its K Salt® is used by the food processing industry to decrease daily dietary intake of sodium, which is associated with elevated blood pressure and high risk of cardiovascular disease.